These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9517957)

  • 1. In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.
    Bébéar CM; Renaudin H; Boudjadja A; Bébéar C
    Antimicrob Agents Chemother; 1998 Mar; 42(3):703-4. PubMed ID: 9517957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.
    Bébéar CM; Renaudin H; Schaeverbeke T; Leblanc F; Bébéar C
    J Antimicrob Chemother; 1999 May; 43(5):711-4. PubMed ID: 10382895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
    Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
    Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB; Cassell GH; Canupp KC; Fernandes PB
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].
    Bauriaud R; Séror C; Lareng MB; Lefèvre JC
    Pathol Biol (Paris); 1992 May; 40(5):479-82. PubMed ID: 1495830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of sparfloxacin against genital pathogens.
    Perea EJ; Aznar J; Garcia-Iglesias MC; Pascual A
    J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Apr; 42(4):951-2. PubMed ID: 9559818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
    Hannan PC; Woodnutt G
    J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Pereyre S; Renaudin H; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3165-8. PubMed ID: 15273141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
    Ridgway GL; Salman H; Robbins MJ; Dencer C; Felmingham D
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():31-4. PubMed ID: 9484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.